Articles and Editorials|

A data-driven approach to the development of medical devices

News Content 1920x630@2x

In the May edition of the ONdrugDelivery magazine, SHL’s Manager of Data and Process Innovation Frederick Gertz, Ph.D, provides an in-depth analysis on the advantages and challenges of becoming a data-driven organization in the medical technology sector.

In a digitalized era, where various tech giants are driving the newest data science trends and reaping results from data-driven decisions, the pharma and medical device industry seems to be moving at a relatively moderate pace. Although it is quite understandable, with life science companies having extraordinary requirements in terms of quality and regulatory standards, this article offers further insights into how digital transformation could benefit these organizations in terms of producing quality results from multiple aspects of development and production.

“Data-driven organizations can better plan logistics, adaptably shift workloads and quickly solve problems,” Gertz said. He also breaks down how transparent data could well streamline communication between designers and manufacturers, thus, giving support in developing products that warrant manufacturability and usability. “By creating a single source of truth, stakeholders across the organization can more easily interact and ultimately collaborate to make products with the highest level of value to everyone,” he explained.

As a leading solutions provider in the drug delivery industry, SHL continues to evolve and adapt to industry changes, implementing data-driven methodologies that ensure better development processes for autoinjector devices.

Download the full article here, or read it online at ONdrugDelivery (log in required).

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News